Click here to download a full transcript of the video.
The ABPI disclosure of payments pages deliver information and updates on our plans to make publicly available details of certain payments to healthcare professionals (HCPs) in the UK.
As an industry we are proud of the relationship between the pharmaceutical industry and HCPs. It is a relationship that has helped develop many life-saving medicines and has long been a positive driver for advancements in patient care and the progression of research. In fact, one-eighth of world’s most popular prescription medicines were developed in the UK as a result of collaboration with HCPs.
There are benefits for HCPs, industry and, most importantly, patients. HCPs need to stay informed about current and new medicines to provide patients with the best possible care and treatment options, and the pharmaceutical industry has a duty to provide HCPs with the latest information on its medicines to help ensure that they are able to make the best treatment recommendations to their patients. Additionally, HCPs provide the pharmaceutical industry with information on how to improve its medicines through feedback about how medicines work in real-world patient settings.
In 2014, we disclosed aggregate payments to HCPs in the region of £38.5 million for payments made in 2013. This was a first step towards being open about the relationships we have with HCPs and paves the way for the next step when, from 2016, pharmaceutical companies will publish payments made to HCPs in 2015, such as fees for service and sponsorship of medical education.
In June 2012, the “code on disclosure of transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations” was announced by the European Federation of Pharmaceutical Industries and Associations (EFPIA). To decide how the EFPIA code should be implemented within the UK as part of the ABPI Code, a
consultation was conducted in 2013 by the Ethical Standards in Health & Life Sciences Group (ESHLG).
The consultation, together with regular dialogue with leading health professional organisations informed the development of the new disclosure scheme which will see the creation of a public database of payments, available through the ABPI website in 2016.
If the company is a member of the ABPI, it will have access to regular updates about individual disclosure through messages to members, the weekly Newsflash, and through member events and forums. Individuals with a more operational interest in the project can get more detailed updates by joining the ABPI’s Disclosure Network. Please email email@example.com to be added to the Disclosure Network distribution list.
Please contact the ABPI by emailing
If HCPs are working with a pharmaceutical company, the company will be able to provide more details about their contract. If an HCP has general queries or a specific query regarding the ABPI Code of Practice, contact the
If an individual has general queries or a specific query regarding the ABPI Code of Practice, contact the